Altered peptide ligands revisited: vaccine design through chemically modified HLA-A2-restricted T cell epitopes. - Hoppes R; Oostvogels R; Luimstra JJ; Wals K; Toebes M; Bies L; Ekkebus R; Rijal P; Celie PH; Huang JH; Emmelot ME; Spaapen RM; et al. (Journal of immunology (Baltimore, Md. : 1950), 2014)